Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prianka Singh

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 13, 2025
Eliciting Unreported Subgroup-Specific Survival from Aggregate Randomized Controlled Trial DataOguzhan Alagoz, Prianka Singh, Matthew Dixon, et al.
CNS Oncology|August 11, 2021
Treatment patterns and outcomes for patients with newly diagnosed glioblastoma multiforme: a retrospective cohort studySrinivas Annavarapu, Anagha Gogate, Trang Pham, et al.
Journal of Medical Economics|October 5, 2019
Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agentsPranav Abraham, Jonathan Karl Kish, Beata Korytowsky, et al.
Head & Neck|September 6, 2021
Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and GermanyPrianka Singh, Laura McDonald, Daniela Waldenberger, et al.
Journal of Managed Care & Specialty Pharmacy|March 28, 2019
A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United StatesAndrew D Norden, Beata Korytowsky, Min You, et al.
European Journal of Cancer (Oxford, England : 1990)|May 23, 2022
Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysisJaffer A Ajani, Lisa Leung, Prianka Singh, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 9, 2025
Q-TWiST analysis of first-line nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma from CheckMate 649: 4-year follow-up resultsDaniel Lin, Wenying Quan, Marne Garretson, et al.
BMC Cancer|July 25, 2021
Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in EuropePrianka Singh, Bryan Bennett, Tom Bailey, et al.
Advances in Therapy|July 28, 2021
Real-World Treatment Patterns and Outcomes in Patients with Head and Neck Cancer: Point-in-Time Survey of Oncologists in Italy and SpainPrianka Singh, Marta Contente, Bryan Bennett, et al.
Current Medical Research and Opinion|October 10, 2015
Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillationSteve Deitelzweig, Michael Evans, Eric Hillson, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 13, 2025
Eliciting Unreported Subgroup-Specific Survival from Aggregate Randomized Controlled Trial DataOguzhan Alagoz, Prianka Singh, Matthew Dixon, et al.
CNS Oncology|August 11, 2021
Treatment patterns and outcomes for patients with newly diagnosed glioblastoma multiforme: a retrospective cohort studySrinivas Annavarapu, Anagha Gogate, Trang Pham, et al.
Journal of Medical Economics|October 5, 2019
Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agentsPranav Abraham, Jonathan Karl Kish, Beata Korytowsky, et al.
Head & Neck|September 6, 2021
Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and GermanyPrianka Singh, Laura McDonald, Daniela Waldenberger, et al.
Journal of Managed Care & Specialty Pharmacy|March 28, 2019
A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United StatesAndrew D Norden, Beata Korytowsky, Min You, et al.
European Journal of Cancer (Oxford, England : 1990)|May 23, 2022
Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysisJaffer A Ajani, Lisa Leung, Prianka Singh, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 9, 2025
Q-TWiST analysis of first-line nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma from CheckMate 649: 4-year follow-up resultsDaniel Lin, Wenying Quan, Marne Garretson, et al.
BMC Cancer|July 25, 2021
Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in EuropePrianka Singh, Bryan Bennett, Tom Bailey, et al.
Advances in Therapy|July 28, 2021
Real-World Treatment Patterns and Outcomes in Patients with Head and Neck Cancer: Point-in-Time Survey of Oncologists in Italy and SpainPrianka Singh, Marta Contente, Bryan Bennett, et al.
Current Medical Research and Opinion|October 10, 2015
Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillationSteve Deitelzweig, Michael Evans, Eric Hillson, et al.
Pageof 3